期刊文献+

宫颈管型腺癌的人乳头瘤病毒感染及p16和孕激素受体的染色特征 被引量:5

p16 and PR immunoreactivity and human papillomavirus infection in endocervical adenocarcinoma
原文传递
导出
摘要 目的探讨宫颈管型腺癌的人乳头瘤病毒(HPV)感染情况及其p16和孕激素受体(PR)染色特征。方法收集中国医学科学院肿瘤医院2005年1月至2010年12月宫颈管型腺癌的蜡块62例,进行三明治切片,采用SPF-10 PCR对蜡卷进行HPV DNA的检测和分型,采用免疫组化SP法对p16和PR进行染色。结果62例宫颈管型腺癌中,HPV阳性46例,阳性率为74.2%;其中4例合并宫颈鳞状上皮内瘤变3级者均HPV阳性。46例HPV阳性病例中,HPV18型单一型别感染22例,占全部HPV阳性患者的47.8%;HPV16型14例,占全部HPV阳性患者的30.4%;HPV59型1例,占全部HPV阳性患者的2.2%;多重感染9例,占全部HPV阳性患者的19.6%。16例HPV阴性者的年龄为(49.6±10.5)岁,46例HPV阳性者的年龄为(42.8±9.7)岁,差异有统计学意义(P=0.022)。p16染色阳性率为80.6%。p16染色结果和HPV检测结果显示,2种方法的检测结果无关联性(P=0.077)。PR染色阳性率为3.2%。肿瘤周围可见残存正常宫颈管腺体24例,其中正常宫颈管腺体PR阳性19例,阳性率为79.2%。肿瘤性腺体和正常宫颈管腺体的PR阳性率比较,差异有统计学意义(P〈0.001)。结论宫颈管型腺癌HPV感染率为74.2%,主要为HPV16型和HPV18型。p16染色阳性尚不能说明宫颈管型腺癌具有高危型HPV感染。PR染色结果可以作为鉴别诊断肿瘤性腺体和正常颈管腺体的参考指标之一。 Objective The aim of this study was to investigate the characteristics of p16 and PR immunoreactivity and HPV infection in endocervical adenocarcinoma. Methods Paraffin blocks of 62 patients with endocervical adnocarcinoma treated in the Cancer Institute and Hospital, Chinese Academy of Medical Sciences from year 2005 to year 2010 were collected, p16 and PR immunostaining and HPV detecting by SPF-10 PCR were conducted on all cases. Results HPV infection rate of the 62 endocervical adnocarcinoma cases was 74.2% with four cases combined with CIN3. Among the 46 HPV-positive cases, there were 22 cases of HPV18 infection (47.8%), 14 cases of HPV16 infection (30.4%), one case of HPV59 infection (2.2%). and nine multiple HPV infection cases ( 19.6% ). The mean age of the 16 HPV-negative cases was (49.6 ± 10.5)year,while the mean age of the 46 HPV-positive cases was (42.8 ± 9.7 )year, showing a significant difference between the two subgroups (P = 0. 022). The positive rate of p16 infection was 80.6%. Association analysis showed that the results of p16 and HPV test were independent to each other (P = 0. 077). The positive rate of PR was 3.2%. Among the 62 cases, there were 24 cases containing normal cervical glands, with 19 cases PR-positive in the normal cervical glands and the positive rate was 79.2%. The difference of PR positivity between neoplastic glands and normal glands was statistically significant by Chi-square test(P 〈 0.01 ). Conclusions The HPV infection rate of endocervical adnocarcinoma is 74.2%, and the major subtypes were HPV16 and HPV18 infection, p16 immunoreactivity in endocervical adenocarcinoma maybe not the proof of high-risk HPV-related neoplasm. PR staining can be used as a reference designator to differentiate between neoplastic and normal cervical glands.
出处 《中华肿瘤杂志》 CAS CSCD 北大核心 2014年第4期263-267,共5页 Chinese Journal of Oncology
关键词 宫颈肿瘤 腺癌 人乳头瘤病毒 免疫组织化学 诊断 Uterine cervical neoplasms Adenocarcinoma Human papillomavirus Immunohistochemistry Diagnosis
  • 相关文献

参考文献18

  • 1Smith HO, Tiffany MF, Qualls CR, et al. The rising incidence of adenocarcinoma relative to squamous cell carcinoma of the uterine cervix in the United States: a 24-year population-based study [J] . Gynecol Oncol, 2000, 78 (2) : 97 -105.
  • 2Zappa M, Visioli CB, Ciatto S, et al. Lower protection of cytological screening for adenocarcinomas and shorter protection for younger women: the results of a case-control study in Florence [J]. Br J Cancer, 2004, 90(9) :1784-1786.
  • 3Vizcaino AP, Moreno V, Bosch FX, et al. International trends in the incidence of cervical cancer: I. Adenocarcinoma and adenosquamous cell carcinomas [J]. Int J Cancer, 1998, 75 ( 4 ) : 536-545.
  • 4Houghton 0, Jamison J, Wilson R, et al. p16 Immunoreactivity in unusual types of cervical adenocarcinoma does not reflect human papillomavirus infection [J]. Histopathology, 2010, 57 (3) : 342- 350.
  • 5Park KJ, Kiyokawa T, Soslow RA, et al. Unusual endocervical adenocarcinomas: an immunohistochemical analysis with molecular detection of human papillomavirus [J ]. Am J Surg Pathol, 2011, 35 (5) :633-646.
  • 6Pirog EC, Kleter B, Olgae S, et al. Prevalence of human papillomavirus DNA in different histological subtypes of cervical adenocarcinoma [J]. Am J Pathol, 2000,157(4) :1055-1062.
  • 7An HJ, Kim KR, Kim IS, et al. Prevalence of human papillomavirus DNA in various histological subtypes of cervical adenocarcinoma: a population-based study [J]. Mod Pathol, 2005, 18 (4) :528-534.
  • 8Y rung RH, Clement PB. Endocervical adenocarcinoma and its variants: their morphology and differential diagnosis [J ]. Histopathology, 2002, 41 (3) : 185-207.
  • 9Muller S, Flores-Staino C, Skyldberg B, et al. Expression of p16JNMa and MIB-l in relation to histopathology and HPV types in cervical adenocarcinoma[J]. Int J Oncol, 2008, 32(2) :333-340.
  • 10Kleter B, van Doom IJ, ter Schegget J, et al. Novel short-fragment PCR assay for highly sensitive broad-spectrum detection of anogenital human papillomaviruses [J]. Am J Pathol, 1998, 153 (6) : 1731-1739.

同被引文献70

  • 1伊喜苓,林蓓,朱连成,张宇华,张帆,齐跃,王冬冬,张淑兰.269例子宫颈微偏腺癌的meta分析[J].中国医科大学学报,2009,38(5):369-372. 被引量:18
  • 2李旻,曹箭,王乃鹏,李龙玉,李凌,乔友林,潘秦镜.p16^(INK4a)免疫细胞化学检测在筛查宫颈癌中的作用[J].中华肿瘤杂志,2006,28(9):674-677. 被引量:9
  • 3杨竹林,杨晓静,付汐,苗雄鹰,黄江生.胆囊腺癌中Caspase-1、白细胞介素-18表达和肿瘤相关巨噬细胞计数的意义[J].中华消化杂志,2007,27(8):564-565. 被引量:1
  • 4PisaniP, BrayF, ParkinMD. Estimates of the world-wide prevalence of cancer for 25 sites in the adult population[J]. Int J Cancer, 2002, 97(1):72-81. DOI:10.1002/ijc.1571.
  • 5VizcainoAP, MorenoV, BoschFX, et al. International trends in the incidence of cervical cancer: I. Adenocarcinoma and adenosquamous cell carcinomas[J]. Int J Cancer, 1998, 75(4):536-545. DOI:10.1016/S1470-2045(10)70230-8.
  • 6ZappaM, VisioliCB, CiattoS, et al. Lower protection of cytological screening for adenocarcinomas and shorter protection for younger women: the results of a case-control study in Florence[J]. Br J Cancer, 2004, 90(9):1784-1786. DOI:10.1038/sj.bjc.6601754.
  • 7SmithHO, TiffanyMF, QuallsCR, et al. The rising incidence of adenocarcinoma relative to squamous cell carcinoma of the uterine cervix in the United States: a 24-year population-based study[J]. Gynecol Oncol, 2000, 78(2):97-105. DOI:10.1006/gyno.2000.5826.
  • 8WalboomersJM, JacobsMV, ManosMM, et al. Human papillomavirus is a necessary cause of invasive cervical cancer worldwide[J]. J Pathol, 1999, 189(1):12-19. DOI:10.1002/(SICI)1096-9896(199909)189:1<12::AID-PATH431>3.0.CO;2-F.
  • 9WoodmanCB, CollinsS, WinterH, et al. Natural history of cervical human papillomavirus infection in young women: a longitudinal cohort study[J]. Lancet, 2001, 357(9271):1831-1836. DOI:10.1016/S0140-6736(00)04956-4.
  • 10HoughtonO, JamisonJ, WilsonR, et al. p16 Immunoreactivity in unusual types of cervical adenocarcinoma does not reflect human papillomavirus infection[J]. Histopathology, 2010, 57(3):342-350. DOI:10.1111/j.1365-2559.2010.03632.x.

引证文献5

二级引证文献43

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部